Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technická 3, 166 28 Prague, Czech Republic.
Bioinova, s.r.o., Vídeňská 1083, 140 20 Praha, Czech Republic.
Molecules. 2021 Apr 12;26(8):2228. doi: 10.3390/molecules26082228.
Prostate cancer is a very common disease, which is, unfortunately, often the cause of many male deaths. This is underlined by the fact that the early stages of prostate cancer are often asymptomatic. Therefore, the disease is usually detected and diagnosed at late advanced or even metastasized stages, which are already difficult to treat. Hence, it is important to pursue research and development not only in terms of novel diagnostic methods but also of therapeutic ones, as well as to increase the effectiveness of the treatment by combinational medicinal approach. Therefore, in this review article, we focus on recent approaches and novel potential tools for the treatment of advanced prostate cancer; these include not only androgen deprivation therapy, antiandrogen therapy, photodynamic therapy, photothermal therapy, immunotherapy, multimodal therapy, but also poly(ADP-ribose) polymerase, Akt and cyclin-dependent kinase inhibitors.
前列腺癌是一种非常常见的疾病,不幸的是,它常常是许多男性死亡的原因。这一点被以下事实所强调:前列腺癌的早期阶段通常没有症状。因此,这种疾病通常在晚期或甚至转移阶段被发现和诊断,而此时已经很难治疗。因此,不仅要追求新的诊断方法,而且要追求治疗方法的研究和开发,以及通过联合药物治疗来提高治疗效果是很重要的。因此,在这篇综述文章中,我们专注于治疗晚期前列腺癌的最新方法和新的潜在工具;这些方法不仅包括雄激素剥夺疗法、抗雄激素疗法、光动力疗法、光热疗法、免疫疗法、多模态疗法,还包括聚(ADP-核糖)聚合酶、Akt 和细胞周期蛋白依赖性激酶抑制剂。